Sumitomo Pharma America loosened or ended its 340B contract pharmacy restrictions in an additional five states.
Sumitomo Loosens 340B Contract Pharmacy Restrictions in Five More States
Drugmaker Sumitomo Pharma America (SMPA) is partially or fully exempting providers in five additional states from its 340B contract pharmacy [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.